Interdict Bio
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Interdict Bio operates in Healthcare & Life Sciences and is based in South San Francisco, California. It was founded in 2022.
Interdict Bio is a biotechnology company that develops small molecule therapeutics targeting historically undruggable proteins in oncology, rare diseases, neurodegeneration, and autoimmunity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Interdict Bio Comparables
Compare Interdict Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Initial Therapeutics | 89% | |
| Arrakis Therapeutics | 77% | |
| Anima Biotech | 76% |
For institutional investors. Book with your work email.
Interdict Bio Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Interdict Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Altitude Life Science Ventures | Seed |
| Venrock | Seed |
| Mission Bay Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 924% MoM.
- Jan 21, 2026
Monthly visitors increased by 50% MoM.
For institutional investors. Book with your work email.
Interdict Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Interdict Bio's valuation, stock price, and market status.
Is Interdict Bio a public or private company?
Interdict Bio is a private company.
What is the current stock price of Interdict Bio?
Interdict Bio is a private company, so its shares have no public market price. Caplight tracks Interdict Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Interdict Bio worth (valuation)?
Valuation information for Interdict Bio is not publicly available.
Can I buy Interdict Bio stock?
Interdict Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Interdict Bio's last funding round?
Funding round information for Interdict Bio is not publicly available.
Who are the main investors in Interdict Bio?
Key investors in Interdict Bio include Altitude Life Science Ventures, Venrock, Mission Bay Capital.
Will Interdict Bio IPO soon?
No public IPO plans have been announced for Interdict Bio.
How can I track Interdict Bio secondary market activity?
Caplight tracks bids, offers, and trades in Interdict Bio's shares on secondary markets.